255 related articles for article (PubMed ID: 16050815)
1. Pharmacokinetics of imipenem-cilastatin following intravenous administration in healthy adult horses.
Orsini JA; Moate PJ; Boston RC; Norman T; Engiles J; Benson CE; Poppenga R
J Vet Pharmacol Ther; 2005 Aug; 28(4):355-61. PubMed ID: 16050815
[TBL] [Abstract][Full Text] [Related]
2. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
Orsini JA; Moate PJ; Engiles J; Norman T; Poppenga R; Benson CE; Boston RC
J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of imipenem in healthy volunteers following administration by 2 h or 0.5 h infusion.
Jaruratanasirikul S; Raungsri N; Punyo J; Sriwiriyajan S
J Antimicrob Chemother; 2005 Dec; 56(6):1163-5. PubMed ID: 16234333
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation.
Lomaestro BM; Drusano GL
Antimicrob Agents Chemother; 2005 Jan; 49(1):461-3. PubMed ID: 15616337
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
Singlas E
Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
Davis JL; Salmon JH; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intravenous ceftiofur sodium and concentration in body fluids of foals.
Meyer S; Giguère S; Rodriguez R; Zielinski RJ; Grover GS; Brown SA
J Vet Pharmacol Ther; 2009 Aug; 32(4):309-16. PubMed ID: 19614835
[TBL] [Abstract][Full Text] [Related]
10. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
Pezé P; Mounier M; Cevallos R; Denis F
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
[TBL] [Abstract][Full Text] [Related]
12. Synovial fluid and plasma concentrations of ceftiofur after regional intravenous perfusion in the horse.
Pille F; De Baere S; Ceelen L; Dewulf J; Croubels S; Gasthuys F; De Backer P; Martens A
Vet Surg; 2005; 34(6):610-7. PubMed ID: 16343149
[TBL] [Abstract][Full Text] [Related]
13. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
Keller E; Fecht H; Böhler J; Schollmeyer P
Nephrol Dial Transplant; 1989; 4(7):640-5. PubMed ID: 2510062
[TBL] [Abstract][Full Text] [Related]
14. Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients.
Benoni G; Cuzzolin L; Bertrand C; Pucchetti V; Velo G
Chemioterapia; 1987 Jun; 6(2 Suppl):259-60. PubMed ID: 3509404
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats.
Albarellos GA; Denamiel GA; Montoya L; Quaine PC; Lupi MP; Landoni MF
J Feline Med Surg; 2013 Jun; 15(6):483-7. PubMed ID: 23253883
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Davis JL; Papich MG; Weingarten A
J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
[TBL] [Abstract][Full Text] [Related]
18. Chronopharmacokinetics of imipenem in the rat.
Boulamery A; Kadra G; Simon N; Besnard T; Bruguerolle B
Chronobiol Int; 2007; 24(5):961-8. PubMed ID: 17994349
[TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin as empirical treatment of severe infections in compromised patients.
Biglino A; Bonasso M; Gioannini P
J Chemother; 1991 Jan; 3 Suppl 1():208-12. PubMed ID: 12041767
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL
J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
